Skip to main content

Table 1 Patient characteristics of the 240 patients with MIBC treated with radical cystectomy 2001–2014

From: A retrospective evaluation of preoperative anemia in patients undergoing radical cystectomy for muscle-invasive urothelial urinary bladder cancer, with or without neoadjuvant chemotherapy

Parameter All patients (n = 240) Non-anemic (n = 112) Anemic (n = 128) p value
Age (years) 69 (62–75) 68 (61–73) 71 (65–76) 0.004
Sex     0.145
 Male 176 (73.3) 77 (68.8) 99 (77.3)  
 Female 64 (26.7) 35 (31.2) 29 (22.7)  
BMI 25.5 (22.8–28.4) 25.8 (23.8–28.8) 24.9 (22.5–27.8) 0.054
 Missing data 20 10 10  
ASA score     0.024
 I 28 (11.8) 19 (17.3) 9 (7.1)  
 II 120 (50.6) 57 (51.8) 63 (49.6)  
 III 86 (36.3) 32 (29.1) 54 (42.5)  
 IV 3 (1.3) 2 (1.8) 1 (0.8)  
 Missing data 3 2 1  
Prior heart attack 33 (13.8) 15 (13.4) 18 (14.1) 1
Hypertonia 104 (43.3) 51 (45.5) 53 (41.4) 0.602
Atrial fibrillation 19 (7.9) 8 (7.1) 11 (8.6) 0.812
Asthma/COPD 17 (7.1) 11 (9.8) 6 (4.7) 0.137
Diabetes mellitus 29 (12.1) 13 (11.6) 16 (12.5) 0.845
Hydronephrosis 63 (26.3) 19 (17) 44 (34.4) 0.003
Neoadjuvant chemotherapy 87 (36.3) 17 (15.2) 70 (54.7) <0.001
EBL (mL) 1000 (700–1712.5) 1200 (725–2000) 1000 (650–1475) 0.035
 Missing data 26 15 11  
Units of PBT 4 (2–6) 2 (1–6) 4 (2–6) 0.003
cT     0.017
 cT2 178 (72.2) 92 (82.1) 86 (67.2)  
 cT3 51 (21.3) 18 (16.1) 33 (25.8)  
 cT4 11 (4.6) 2 (1.8) 9 (7.0)  
Year of surgery     0.469
 2001–2002 20 (8.3) 12 (10.7) 8 (6.3)  
 2003–2005 43 (17.9) 21 (18.8) 22 (17.2)  
 2006–2008 55 (22.9) 27 (24.1) 28 (21.9)  
 2009–2011 73 (30.4) 34 (30.4) 39 (30.5)  
 2012–2014 49 (20.4) 18 (16.1) 31 (24.2)  
  1. Data are shown as median (IQR) or n (%)
  2. BMI body mass index, ASA American Society of Anesthesiologists, COPD  chronic obstructive pulmonary disease, EBL estimated blood loss, PBT perioperative blood transfusion, cT clinical tumour stage